Gregory J. Tryder

Array ( [id] => 463906 [patent_doc_number] => 07238719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Process for producing 1,2,3-Triazole compounds' [patent_app_type] => utility [patent_app_number] => 10/502392 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3942 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238719.pdf [firstpage_image] =>[orig_patent_app_number] => 10502392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083903 [patent_doc_number] => 20050049283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Compounds that inhibit factor xa activity' [patent_app_type] => utility [patent_app_number] => 10/501932 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9713 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049283.pdf [firstpage_image] =>[orig_patent_app_number] => 10501932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7146622 [patent_doc_number] => 20050119492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Process for the preparation of high purity perindopril and intermediates useful in the synthesis' [patent_app_type] => utility [patent_app_number] => 10/503272 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4539 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119492.pdf [firstpage_image] =>[orig_patent_app_number] => 10503272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163721 [patent_doc_number] => 20050085541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof' [patent_app_type] => utility [patent_app_number] => 10/502737 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54839 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085541.pdf [firstpage_image] =>[orig_patent_app_number] => 10502737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952883 [patent_doc_number] => 20050227978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Fibrosis inhibitor' [patent_app_type] => utility [patent_app_number] => 10/502933 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 86779 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227978.pdf [firstpage_image] =>[orig_patent_app_number] => 10502933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991361 [patent_doc_number] => 20050090398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Novel tetrazole derivative useful as herbicides' [patent_app_type] => utility [patent_app_number] => 10/503771 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46871 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090398.pdf [firstpage_image] =>[orig_patent_app_number] => 10503771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7146568 [patent_doc_number] => 20050119482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/500972 [patent_app_country] => US [patent_app_date] => 2003-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33780 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119482.pdf [firstpage_image] =>[orig_patent_app_number] => 10500972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 497711 [patent_doc_number] => 07208527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-24 [patent_title] => 'Potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 10/496859 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23841 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/208/07208527.pdf [firstpage_image] =>[orig_patent_app_number] => 10496859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117292 [patent_doc_number] => 20050070593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Novel process for the preparation of trans-3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl) amino]carbonyl] amino]sulfonyl] phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide' [patent_app_type] => utility [patent_app_number] => 10/501743 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5185 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070593.pdf [firstpage_image] =>[orig_patent_app_number] => 10501743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145597 [patent_doc_number] => 20050119246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => '1H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor' [patent_app_type] => utility [patent_app_number] => 10/499786 [patent_app_country] => US [patent_app_date] => 2002-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20644 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119246.pdf [firstpage_image] =>[orig_patent_app_number] => 10499786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7051388 [patent_doc_number] => 20050187275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Triazoles as oxytocin antagonists' [patent_app_type] => utility [patent_app_number] => 10/498356 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20232 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187275.pdf [firstpage_image] =>[orig_patent_app_number] => 10498356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163674 [patent_doc_number] => 20050085530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 10/496730 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4855 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085530.pdf [firstpage_image] =>[orig_patent_app_number] => 10496730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026756 [patent_doc_number] => 20050020585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5' [patent_app_type] => utility [patent_app_number] => 10/499391 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17908 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020585.pdf [firstpage_image] =>[orig_patent_app_number] => 10499391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7146619 [patent_doc_number] => 20050119491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => '2, 7-Substituted carbazoles and oligomers, polymers and co-polymers thereof' [patent_app_type] => utility [patent_app_number] => 10/498716 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14652 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119491.pdf [firstpage_image] =>[orig_patent_app_number] => 10498716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686933 [patent_doc_number] => 07078415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders' [patent_app_type] => utility [patent_app_number] => 10/496020 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13999 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078415.pdf [firstpage_image] =>[orig_patent_app_number] => 10496020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913035 [patent_doc_number] => 20050176793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Amorphous form of 2-n-butyl-3-((2-(1h-tetrazol-5-yl)([1,1\'-biphenyl)-4-yl)methyl)-1, 3-diazaspiro(4,4\')non-1-en-4-one' [patent_app_type] => utility [patent_app_number] => 10/498197 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2635 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176793.pdf [firstpage_image] =>[orig_patent_app_number] => 10498197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255373 [patent_doc_number] => 20050075345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Novel inhibitor compounds specific of secreted non-pancreatic human a2phospholipase of group II' [patent_app_type] => utility [patent_app_number] => 10/497742 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16577 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075345.pdf [firstpage_image] =>[orig_patent_app_number] => 10497742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026300 [patent_doc_number] => 20050020439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same' [patent_app_type] => utility [patent_app_number] => 10/495645 [patent_app_country] => US [patent_app_date] => 2002-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28238 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020439.pdf [firstpage_image] =>[orig_patent_app_number] => 10495645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924163 [patent_doc_number] => 20060241087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity' [patent_app_type] => utility [patent_app_number] => 10/498313 [patent_app_country] => US [patent_app_date] => 2002-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28081 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241087.pdf [firstpage_image] =>[orig_patent_app_number] => 10498313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061813 [patent_doc_number] => 20050004175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Novel 1 2 4-triazole compound' [patent_app_type] => utility [patent_app_number] => 10/495322 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7481 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004175.pdf [firstpage_image] =>[orig_patent_app_number] => 10495322 [rel_patent_id] =>[rel_patent_doc_number] =>)